Hospital General de Granollers-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2020

  1. The persistent breach between evidence and practice in the prevention of surgical site infection. Qualitative study

    International Journal of Surgery

2019

  1. Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study

    Clinical Breast Cancer, Vol. 19, Núm. 2, pp. 105-112

2011

  1. Individualization of treatment strategies

    Advances in Therapy, Vol. 28, Núm. SUPPL. 6, pp. 19-38